Icu Medical Stock Current Valuation
| ICUI Stock | USD 147.07 1.02 0.69% |
Valuation analysis of ICU Medical helps investors to measure ICU Medical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of now, ICU Medical's Enterprise Value Over EBITDA is increasing as compared to previous years. The ICU Medical's current Enterprise Value Multiple is estimated to increase to 123.63, while Enterprise Value is projected to decrease to under 243.3 M. Fundamental drivers impacting ICU Medical's valuation include:
Overvalued
Today
Please note that ICU Medical's price fluctuation is very steady at this time. Calculation of the real value of ICU Medical is based on 3 months time horizon. Increasing ICU Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since ICU Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ICU Stock. However, ICU Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 147.07 | Real 125.26 | Target 203.4 | Hype 147.07 | Naive 155.24 |
The intrinsic value of ICU Medical's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence ICU Medical's stock price.
Estimating the potential upside or downside of ICU Medical helps investors to forecast how ICU stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ICU Medical more accurately as focusing exclusively on ICU Medical's fundamentals will not take into account other important factors: ICU Medical Company Current Valuation Analysis
ICU Medical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current ICU Medical Current Valuation | 4.94 B |
Most of ICU Medical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ICU Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ICU Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for ICU Medical is extremely important. It helps to project a fair market value of ICU Stock properly, considering its historical fundamentals such as Current Valuation. Since ICU Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICU Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICU Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
ICU Current Valuation Historical Pattern
Today, most investors in ICU Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICU Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ICU Medical current valuation as a starting point in their analysis.
ICU Medical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, ICU Medical has a Current Valuation of 4.94 B. This is 65.61% lower than that of the Health Care Equipment & Supplies sector and 45.98% lower than that of the Health Care industry. The current valuation for all United States stocks is 70.29% higher than that of the company.
ICU Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICU Medical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICU Medical could also be used in its relative valuation, which is a method of valuing ICU Medical by comparing valuation metrics of similar companies.ICU Medical is currently under evaluation in current valuation category among its peers.
ICU Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ICU Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ICU Medical's managers, analysts, and investors.Environmental | Governance | Social |
ICU Fundamentals
| Return On Equity | -0.0576 | ||||
| Return On Asset | 0.0142 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 4.94 B | ||||
| Shares Outstanding | 24.52 M | ||||
| Shares Owned By Insiders | 7.83 % | ||||
| Shares Owned By Institutions | 99.80 % | ||||
| Number Of Shares Shorted | 786.38 K | ||||
| Price To Earning | 38.71 X | ||||
| Price To Book | 1.83 X | ||||
| Price To Sales | 1.51 X | ||||
| Revenue | 2.38 B | ||||
| Gross Profit | 824.78 M | ||||
| EBITDA | 42.96 M | ||||
| Net Income | (117.69 M) | ||||
| Cash And Equivalents | 285.59 M | ||||
| Cash Per Share | 11.95 X | ||||
| Total Debt | 1.58 B | ||||
| Debt To Equity | 0.84 % | ||||
| Current Ratio | 2.45 X | ||||
| Book Value Per Share | 80.16 X | ||||
| Cash Flow From Operations | 204.03 M | ||||
| Short Ratio | 3.55 X | ||||
| Earnings Per Share | (4.82) X | ||||
| Price To Earnings To Growth | 1.70 X | ||||
| Target Price | 190.0 | ||||
| Number Of Employees | 15 K | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 3.61 B | ||||
| Total Asset | 4.2 B | ||||
| Retained Earnings | 690.16 M | ||||
| Working Capital | 885.8 M | ||||
| Current Asset | 505.01 M | ||||
| Current Liabilities | 42.62 M | ||||
| Net Asset | 4.2 B |
About ICU Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ICU Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICU Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ICU Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether ICU Medical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ICU Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Icu Medical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Icu Medical Stock:Check out ICU Medical Piotroski F Score and ICU Medical Altman Z Score analysis. For more detail on how to invest in ICU Stock please use our How to Invest in ICU Medical guide.You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ICU Medical. If investors know ICU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ICU Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.24) | Earnings Share (4.82) | Revenue Per Share | Quarterly Revenue Growth 0.071 | Return On Assets |
The market value of ICU Medical is measured differently than its book value, which is the value of ICU that is recorded on the company's balance sheet. Investors also form their own opinion of ICU Medical's value that differs from its market value or its book value, called intrinsic value, which is ICU Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ICU Medical's market value can be influenced by many factors that don't directly affect ICU Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ICU Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if ICU Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ICU Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.